FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006066141> ?p ?o ?g. }

• W2006066141 endingPage "355" @default.
• W2006066141 startingPage "349" @default.
• W2006066141 abstract "Preclinical studies have emphasized that persistent small afferent input will induce a state of central facilitation, which can be regulated by systemically administered sodium channel blockers. We have extended these preclinical studies to the human volunteers by examining the effects of lamotrigine and 4030W92, two structurally related voltage-sensitive sodium channel antagonists, on acute sensory thresholds and facilitated processing induced by intradermal capsaicin. Fifteen healthy subjects received 4030W92, lamotrigine, and placebo in a randomized order using double-blinded crossover design methodology in three sessions each separated by a 7-day washout period. In each session, baseline neurosensory testing was performed on the volar aspect of the subject's left forearm. Subjects were then dosed with either lamotrigine (300 mg), 4030W92 (100 mg), or placebo, followed 2 h later by capsaicin (100 μg) injected intradermally on the volar aspect of the left forearm. Pain scores, blood pressure, heart rate, and respiratory rate were measured at the time of injection and every 5 min for 15 min. Fifteen minutes after the capsaicin injection, the hyperalgesic area was determined by von Frey hair, stroking, and heat; the flare response was outlined; and neurosensory testing again was performed halfway between the edge of the hyperalgesic area and the capsaicin injection site. While capsaicin significantly decreased the hot pain and VF pain thresholds, oral lamotrigine and 4030W92 failed to alter this response to capsaicin, relative to placebo treatment. Similarly, oral lamotrigine or 4030W92 did not alter the pain scores reported from mechanical pain stimuli at any time postcapsaicin. This study showed a lack of effect of two structurally similar sodium channel antagonists on a human experimental pain model using intradermal capsaicin, which is consistent with other studies on the effects of sodium channel antagonists of capsaicin-induced pain and hyperalgesia. This lack of effect stands in contrast to reported effects of sodium channel antagonists on preclinical models of cutaneous hyperalgesia or effects of lamotrigine on clinical neuropathic pain." @default.
• W2006066141 created "2016-06-24" @default.
• W2006066141 creator A5023024763 @default.
• W2006066141 creator A5027608509 @default.
• W2006066141 creator A5045020425 @default.
• W2006066141 date "2004-06-01" @default.
• W2006066141 modified "2023-10-01" @default.
• W2006066141 title "Lack of effect of two oral sodium channel antagonists, lamotrigine and 4030W92, on intradermal capsaicin-induced hyperalgesia model" @default.
• W2006066141 cites W1822822588 @default.
• W2006066141 cites W1844967107 @default.
• W2006066141 cites W1968974481 @default.
• W2006066141 cites W1972178848 @default.
• W2006066141 cites W1975185129 @default.
• W2006066141 cites W1976695835 @default.
• W2006066141 cites W1977774988 @default.
• W2006066141 cites W1978132541 @default.
• W2006066141 cites W1979145649 @default.
• W2006066141 cites W1990078084 @default.
• W2006066141 cites W2005647824 @default.
• W2006066141 cites W2013164405 @default.
• W2006066141 cites W2020224172 @default.
• W2006066141 cites W2021399290 @default.
• W2006066141 cites W2022255063 @default.
• W2006066141 cites W2028111627 @default.
• W2006066141 cites W2033989627 @default.
• W2006066141 cites W2037208185 @default.
• W2006066141 cites W2038969610 @default.
• W2006066141 cites W2053864414 @default.
• W2006066141 cites W2057469839 @default.
• W2006066141 cites W2066025380 @default.
• W2006066141 cites W2067320018 @default.
• W2006066141 cites W2077069417 @default.
• W2006066141 cites W2094883552 @default.
• W2006066141 cites W2106088085 @default.
• W2006066141 cites W2135145448 @default.
• W2006066141 cites W2138519759 @default.
• W2006066141 cites W2158067363 @default.
• W2006066141 cites W2317209152 @default.
• W2006066141 cites W4243252909 @default.
• W2006066141 cites W4256531583 @default.
• W2006066141 doi "https://doi.org/10.1016/j.pbb.2004.04.007" @default.
• W2006066141 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15219777" @default.
• W2006066141 hasPublicationYear "2004" @default.
• W2006066141 type Work @default.
• W2006066141 sameAs 2006066141 @default.
• W2006066141 citedByCount "23" @default.
• W2006066141 countsByYear W20060661412012 @default.
• W2006066141 countsByYear W20060661412013 @default.
• W2006066141 countsByYear W20060661412014 @default.
• W2006066141 countsByYear W20060661412015 @default.
• W2006066141 countsByYear W20060661412016 @default.
• W2006066141 countsByYear W20060661412021 @default.
• W2006066141 crossrefType "journal-article" @default.
• W2006066141 hasAuthorship W2006066141A5023024763 @default.
• W2006066141 hasAuthorship W2006066141A5027608509 @default.
• W2006066141 hasAuthorship W2006066141A5045020425 @default.
• W2006066141 hasConcept C118552586 @default.
• W2006066141 hasConcept C126322002 @default.
• W2006066141 hasConcept C141071460 @default.
• W2006066141 hasConcept C142724271 @default.
• W2006066141 hasConcept C15490471 @default.
• W2006066141 hasConcept C170493617 @default.
• W2006066141 hasConcept C203014093 @default.
• W2006066141 hasConcept C204787440 @default.
• W2006066141 hasConcept C27081682 @default.
• W2006066141 hasConcept C2778186239 @default.
• W2006066141 hasConcept C2778802184 @default.
• W2006066141 hasConcept C2778937273 @default.
• W2006066141 hasConcept C2779245659 @default.
• W2006066141 hasConcept C2780051329 @default.
• W2006066141 hasConcept C2780214079 @default.
• W2006066141 hasConcept C42219234 @default.
• W2006066141 hasConcept C71924100 @default.
• W2006066141 hasConcept C87813604 @default.
• W2006066141 hasConcept C98274493 @default.
• W2006066141 hasConceptScore W2006066141C118552586 @default.
• W2006066141 hasConceptScore W2006066141C126322002 @default.
• W2006066141 hasConceptScore W2006066141C141071460 @default.
• W2006066141 hasConceptScore W2006066141C142724271 @default.
• W2006066141 hasConceptScore W2006066141C15490471 @default.
• W2006066141 hasConceptScore W2006066141C170493617 @default.
• W2006066141 hasConceptScore W2006066141C203014093 @default.
• W2006066141 hasConceptScore W2006066141C204787440 @default.
• W2006066141 hasConceptScore W2006066141C27081682 @default.
• W2006066141 hasConceptScore W2006066141C2778186239 @default.
• W2006066141 hasConceptScore W2006066141C2778802184 @default.
• W2006066141 hasConceptScore W2006066141C2778937273 @default.
• W2006066141 hasConceptScore W2006066141C2779245659 @default.
• W2006066141 hasConceptScore W2006066141C2780051329 @default.
• W2006066141 hasConceptScore W2006066141C2780214079 @default.
• W2006066141 hasConceptScore W2006066141C42219234 @default.
• W2006066141 hasConceptScore W2006066141C71924100 @default.
• W2006066141 hasConceptScore W2006066141C87813604 @default.
• W2006066141 hasConceptScore W2006066141C98274493 @default.
• W2006066141 hasIssue "2" @default.
• W2006066141 hasLocation W20060661411 @default.
• W2006066141 hasLocation W20060661412 @default.
• W2006066141 hasOpenAccess W2006066141 @default.

• next